Viemed Healthcare, Inc. (VMD)
Healthcare
- Fundamental
- 4
- Sentiment
- 2
- Technical
- 1
Do Nothing: qualitativeScore is 2 (below required floor of 3), avgDollarVolume20 is about $4.34M (below the $5M liquidity floor), and the post-earnings chart remains broken.
Company overview
Viemed Healthcare, Inc. provides home medical equipment and post-acute respiratory healthcare services in the United States. The company specializes in respiratory disease management, including COPD treatment, and offers a range of medical equipment and services such as ventilators, oxygen therapy, and sleep apnea management. Founded in 2006, Viemed is headquartered in Lafayette, Louisiana.
Fundamental
goodViemed demonstrates strong growth and low leverage, but valuation metrics suggest limited near-term earnings growth support.
Score 4/5. Recent SEC filings show continued growth, covenant compliance, and no going-concern warnings. Financial metrics show low leverage (net debt/EBITDA ~0.02) and strong cash generation (TTM free-cash-flow yield ~8.27%). Valuation looks attractive on EV/EBITDA (~6.61x) and EV/Sales (~1.17x), but P/E (~24.60x), high PEG (~4.43), and mixed discounted-cash-flow signals keep it from a top-tier score.
Sentiment
weakPost-earnings sentiment is negative due to margin pressures and cautious sell-side coverage.
Q2 results (2026-08-03, announced) are still being digested with coverage skewing bearish on an EPS/profit miss and margin pressure, and a fresh sell-side Hold/downgrade (2026-08-06) reinforces the near-term overhang. Media sentiment deteriorated from a positive 30–90d baseline (polarity_score +0.22) to roughly flat/slightly negative in the last 14d (-0.013); no regulator-confirmed investigations surfaced (legal case search partially blocked by CAPTCHA).
Technical
very weakThe stock is oversold with negative momentum, indicating a broken chart with only bounce potential.
VMD's 2026-08-04 earnings gap broke its prior base and left price 9.28 below SMA20 11.18, SMA50 11.07, EMA9 10.11, EMA21 10.79 and daily VWAP 9.32. RSI14 23.03 and Williams %R -97.77 show deep oversold conditions, but MACD -0.52 is still below signal -0.19 and below zero while ADX14 28.01 confirms trend strength on the downside, so this is a broken chart with bounce-only potential, not a confirmed bullish repair.
You’re looking at 2026-08-12 — more than 2 trading days ago.
Subscribers saw this then, and see today’s score, verdict and trade plan now.
More Healthcare
Not financial advice. For informational and educational purposes only.